On a total of 79 biopsies, the assessment of H19 levels in tissues by qRT-PCR showed significant differences between the attributed H19 level means amongst lesions: in comparison to normal lesions (where the predominant tissue corresponds to fibrofatty breast tissue on histology), H19 fold change levels increased gradually in fibroproliferative lesions (fibrocystic/dystrophic changes as per the histology report) (6.9 ± 3.07), followed by fibroadenoma lesions (12.5 ± 4.8). The gene discussed is H19; the disease is Fibroadenoma.